Table 1 Correlation between GFPT1 expression and clinicopathological variables

Age, n (%)

 <  60 years

29 (43.3%)

35 (52.2%)

0.299

 ≥ 60 years

38 (56.7%)

32 (47.8%)

Sex, n (%)

 Male

32 (47.8%)

40 (59.7%)

0.166

 Female

35 (52.2%)

27 (40.3%)

Tumor location, n (%)

 Head and neck

39 (58.2%)

32 (47.8%)

0.229

 Body and tail

28 (41.8%)

35 (52.2%)

Tumor grade, n (%)

 High and intermediate

40 (59.7%)

42 (62.7%)

0.723

 Low

27 (40.3%)

25 (37.3%)

Tumor size, n (%)

 ≤ 4.0 cm

53 (79.1%)

49 (73.1%)

0.418

 > 4.0 cm

14 (20.9%)

18 (26.9%)

Nodal metastasis, n (%)

 Absence

40 (59.7%)

28 (41.8%)

0.038*

 Presence

27 (40.3%)

39 (58.2%)

Perineural infiltration, n (%)

 Absence

10 (89.1%)

13 (77.6%)

0.492

 Presence

57 (10.9%)

54 (22.4%)

Vessel invasion, n (%)

 Absence

51 (76.1%)

57 (85.1%)

0.190

 Presence

16 (23.9%)

10 (14.9%)

CA199 level, n (%)

 ≤ 37 U/ml

26 (38.8%)

19 (28.4%)

0.200

 >  37 U/ml

41 (61.2%)

48 (71.6%)